Retaglutide is a novel GLP-1 receptor agonist currently under investigation for the management of obesity. This medication works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://harmonydktw888287.liberty-blog.com/39228824/semaglutide-a-potential-solution-for-metabolic-disorders